tiprankstipranks
Trending News
More News >
PharmAla Biotech Holdings, Inc. (TSE:MDMA)
:MDMA

PharmAla Biotech Holdings, Inc. (MDMA) Revenue

Compare
63 Followers

PharmAla Biotech Holdings, Inc. Revenue

PharmAla Biotech Holdings, Inc. had a revenue of 267.38K in the quarter ending Nov 30, 2025, with 29.52%. This bring the company's revenue in the last twelve months to 605.50K, Increased -19.76%. In the fiscal year ending Nov 30, 2025, PharmAla Biotech Holdings, Inc. had annual revenue of 605.50K with -41.51% growth.
Revenue (ttm)
605.50K
Revenue Growth
-72.51%
P/S Ratio
17.98
Revenue/Employee
Employees
Market Cap
C$10.89M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Nov 30, 2025
605.50K-429.80K-41.51%
Nov 30, 2024
1.04M503.29K+94.60%
Nov 30, 2023
532.00K453.93K+581.44%
Nov 30, 2022
78.07K+∞%
Aug 31, 2021